Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TBC1 domain family member 28 (TBC1D28) is a human protein encoded by the TBC1D28 gene, located on chromosome 17 (region: 17q11.2). It has been referenced as FLJ40244 in some gene databases. TBC1D28 belongs to the large TBC (Tre2-Bub2-Cdc16) domain-containing protein family, which is generally implicated in the regulation of small GTPase signaling, particularly acting as GTPase-activating proteins (GAPs) for Rab proteins. However, no specific biological function, disease role, therapeutic relevance, interacting drugs, or mechanisms of action have been documented for TBC1D28 in available protein, genomic, or biomedical literature and database sources as of the current date. There is no evidence supporting its status as a direct therapeutic target or biomarker, nor is there information on associated drug interactions or clinical safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TBC1 domain family member 28 (TBC1D28).